Compare FULC & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FULC | SWBI |
|---|---|---|
| Founded | 2015 | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 462.2M | 491.2M |
| IPO Year | 2019 | 2000 |
| Metric | FULC | SWBI |
|---|---|---|
| Price | $7.57 | $14.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $16.38 | $14.00 |
| AVG Volume (30 Days) | ★ 994.3K | 670.3K |
| Earning Date | 04-30-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 3.61% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $474,661,000.00 |
| Revenue This Year | N/A | $7.61 |
| Revenue Next Year | N/A | $3.72 |
| P/E Ratio | ★ N/A | $287.80 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.32 | $7.73 |
| 52 Week High | $15.74 | $15.40 |
| Indicator | FULC | SWBI |
|---|---|---|
| Relative Strength Index (RSI) | 48.10 | 62.59 |
| Support Level | $7.40 | $13.65 |
| Resistance Level | $8.01 | $14.51 |
| Average True Range (ATR) | 0.43 | 0.41 |
| MACD | 0.10 | -0.05 |
| Stochastic Oscillator | 78.43 | 39.43 |
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.